Evidence map›Paper›PMID 29313714›Full record

Trial reportAnnals of the American Thoracic Society2018

Decreased Lung Function and All-Cause Mortality in HIV-infected Individuals.

Matthew R Gingo, Mehdi Nouraie, Cathy J Kessinger, Ruth M Greenblatt, Laurence Huang, Eric C Kleerup, Lawrence Kingsley, Deborah K McMahon, Alison Morris

4 registry-linked trialsOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in Annals of the American Thoracic Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 41 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 3 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00869544 completednot on this map

Pneumocystis in Pathogenesis of HIV-associated Emphysema

TypeobservationalSponsorUniversity of PittsburghRan2007 to 2013Enrolled250ConditionsHIV Infections, Pneumocystis Pneumonia, Emphysema, Chronic Obstructive Pulmonary Disease
NCT01326572 completednot on this map

Prevalence and Pathogenesis of Lung Disease in a Large HIV Cohort-Pitt

TypeobservationalSponsorUniversity of PittsburghRan2009 to 2016Enrolled189ConditionsPulmonary Disease, HIV, Emphysema
NCT02154880 completednot on this map

Translation Evaluation of Aging, Inflammation and HIV in Lung Function

TypeobservationalSponsorUniversity of PittsburghRan2014 to 2020Enrolled323ConditionsHIV, COPD, Pulmonary Disease, AgingArmsPFT, lab work, 6MWT, questionnaires
NCT02238327 completednot on this map

The Study is a Multicenter, Prospective Observational Study of Pathogenesis of HIV Pulmonary Disease.

TypeobservationalSponsorUniversity of PittsburghRan2014 to 2020Enrolled232ConditionsChronic Obstructive Pulmonary Disease, HIV, EmphysemaArmsblood draw, questionnaires, Lung function testing, Six-Minute walk test, Quantitative CT scans
3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 3 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Moderate to Severe Impairment of DlAnnals of the American Thoracic Society · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. HIV-associated lung disease.Nature reviews. Disease primers · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Lung Function in Women With and Without Human Immunodeficiency Virus.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  20. COPD in People with HIV: Epidemiology, Pathogenesis, Management, and Prevention Strategies.International journal of chronic obstructive pulmonary disease · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Matthew R Gingo1 Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Mehdi Nouraie1 Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Cathy J Kessinger1 Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Ruth M Greenblatt2 University of California San Francisco School of Pharmacy, San Francisco, California.
Laurence Huang3 Department of Medicine, University of California San Francisco School of Medicine, San Francisco, California.
Eric C Kleerup4 Departments of Clinical Pharmacology, Epidemiology, and Biostatistics, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California.
Lawrence Kingsley5 Department of Immunology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania; and.
Deborah K McMahon1 Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Alison Morris1 Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
University of Pittsburgh · USUniversity of California, San Francisco · USUniversity of California, Los Angeles · US

Funding

Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
NATURAL HISTORY OF AIDS IN HOMOSEXUAL MENU01AI035040 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DETELS, ROGER, MARTINEZ-MAZA, OTONIEL · 1993 to 2018
$75.2M
University of Pittsburgh Multicenter AIDS Cohort Study (MACS)U01AI035041 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MARTINSON, JEREMY JAMES, RINALDO, CHARLES R · 1993 to 2018
$71.4M
WOMEN'S INTERAGENCY HIV STUDY ORGANIZATION, MANAGEMENT AND COMMUNICATIONSU01AI034989 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AOUIZERAT, BRADLEY E, GREENBLATT, RUTH MARTHA · 1993 to 2018
$65.6M
University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Center for the Analysis & Management of the Multicenter AIDS Cohort StudyUM1AI035043 · NIAID · JOHNS HOPKINS UNIVERSITY · PI D'SOUZA, GYPSYAMBER, JACOBSON, LISA P · 2012 to 2018
$20.7M
Institute for Clinical and Translational ResearchUL1TR000424 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2012 to 2012
$6.0M
Translational evaluation of aging, inflammation, and HIV in lung dysfunctionR01HL120398 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MORRIS, ALISON · 2013 to 2017
$3.4M
Pneumocystis in Pathogenesis of HIV-associated EmphysemaR01HL083461 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MORRIS, ALISON · 2005 to 2009
$2.2M
Patient-Oriented Research and Mentoring in PneumocystisK24HL087713 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, LAURENCE · 2006 to 2018
$1.8M
HIV infection and AsthmaK23HL108697 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GINGO, MATTHEW R. · 2011 to 2015
$662k
NCATS NIH HHS UL1 TR000004NCATS NIH HHS UL1 TR000005NCATS NIH HHS UL1 TR000424NCATS NIH HHS UL1 TR000454NHLBI NIH HHS K23 HL108697NHLBI NIH HHS K24 HL087713NHLBI NIH HHS K24 HL123342NHLBI NIH HHS R01 HL083461NIAID NIH HHS U01 AI034989NIAID NIH HHS U01 AI035040NIAID NIH HHS U01 AI035041NIAID NIH HHS UM1 AI035043
6 · The paper itself

Abstract

rationaleHuman immunodeficiency virus (HIV) infection is associated with pulmonary disease and worse lung function, but the relationship of lung function with survival in HIV is unknown.

objectivesTo determine whether lung function is associated with all-cause mortality in HIV-infected individuals.

methodsHIV-infected participants from cohorts in three locations underwent pre- and post-bronchodilator spirometry and determination of single-breath diffusing capacity of the lung for carbon monoxide (Dl

resultsOverall, 396 HIV-infected participants underwent pulmonary function testing. Thirty-two participants (8%) died during a median follow-up period of 69 months. A post-bronchodilator FEV

conclusionsAirflow obstruction and impaired diffusing capacity appear to be associated with all-cause mortality in HIV-infected persons over an average of 6 years of follow-up. These data highlight the importance of lung dysfunction in HIV-infected persons and should be confirmed in larger cohorts and with extended follow-up periods. Clinical trial registered with www.clinicaltrials.gov (NCT00869544, NCT01326572).

Indexed as

HIV InfectionsLungPulmonary Disease, Chronic ObstructiveAdultAnti-Retroviral AgentsCD4 Lymphocyte CountCorrelation of DataEchocardiographyFemaleFollow-Up StudiesHumansMaleMiddle AgedPulmonary Diffusing CapacityRespiratory Function TestsSurvival AnalysisAnti-Retroviral Agentsacquired immunodeficiency syndromechronic obstructive pulmonary diseaseHIV

Identifiers

PMID29313714
PMCPMC5822404
OpenAlexW2783579897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.